Why the study?
Myocardial no-reflow after PPCI for STEMI is associated with worse outcomes, prompting investigation into whether admission inflammatory and lipid markers and ratios relate to its development.
Do admission CRP/Albumin ratio and Monocytes/HDL ratio predict angiographic no-reflow in patients with STEMI undergoing primary PCI?
Comparison
150 patients with post-revascularization angiographic no-reflow vs 150 matched controls with TIMI III flow
Design
Matched case-control study
Authors
Loading...
May support no-reflow risk stratification in STEMI; hypothesis-generating and should not yet change practice without prospective validation.
Do admission CRP/Albumin ratio and Monocytes/HDL ratio predict angiographic no-reflow in patients with STEMI undergoing primary PCI?
Admission CRP/Albumin ratio and Monocytes/HDL ratio are easily measurable, independent predictors of angiographic no-reflow in STEMI patients undergoing primary PCI.
Khaled Mohamed Said Othman (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: